Evidence map›Paper›PMID 40801733›Full record

ReviewNanomaterials (Basel, Switzerland)2025

Nanoparticle Uptake and Crossing by Human In Vitro Models of Intestinal Barriers: A Scoping Review.

Chiara Ritarossi, Valentina Prota, Francesca De Battistis, Chiara Laura Battistelli, Isabella De Angelis, Cristina Andreoli, Olimpia Vincentini

Abstract readReview
In one paragraph

Review in Nanomaterials (Basel, Switzerland), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Chiara RitarossiEnvironment and Health Department, Istituto Superiore di Sanità, 00161 Rome, Italy.ORCID 0009-0008-7114-5051
Valentina ProtaFood Safety, Nutrition and Veterinary Public Health Department, Istituto Superiore di Sanità, 00161 Rome, Italy.ORCID 0000-0003-2336-9954
Francesca De BattistisFood Safety, Nutrition and Veterinary Public Health Department, Istituto Superiore di Sanità, 00161 Rome, Italy.ORCID 0000-0002-7246-1290
Chiara Laura BattistelliEnvironment and Health Department, Istituto Superiore di Sanità, 00161 Rome, Italy.ORCID 0000-0003-2386-0727
Isabella De AngelisEnvironment and Health Department, Istituto Superiore di Sanità, 00161 Rome, Italy.
Cristina AndreoliEnvironment and Health Department, Istituto Superiore di Sanità, 00161 Rome, Italy.ORCID 0000-0003-3724-0668
Olimpia VincentiniFood Safety, Nutrition and Veterinary Public Health Department, Istituto Superiore di Sanità, 00161 Rome, Italy.ORCID 0000-0002-4137-4135

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The Caco-2 in vitro model of the intestinal barrier is a well-established system for the investigation of the intestinal fate of orally ingested chemicals and drugs, and it has been used for over ten years by pharmaceutical industries as a model for absorption in preclinical studies. The Caco-2 model shows a fair correlation with in vivo drug absorption, though some inherent biases remain unresolved. Its main limitation lies in the lack of structural complexity, as it does not replicate the diverse cell types and mucus layer present in the human intestinal epithelium. Consequently, the development of advanced in vitro models of the intestinal barrier, that more structurally resemble the human intestinal epithelium physiology, has increased the potential applications of these models. Recently, Caco-2-based advanced intestinal models have proven effective in predicting nanomaterial uptake and transport across the intestinal barrier. The aim of this review is to provide a state-of-the-art of human in vitro intestinal barrier models for the study of translocation/uptake of nanoparticles relevant for oral exposure, including inorganic nanomaterials, micro/nano plastic, and fiber nanomaterials. The main effects of the above-mentioned nanomaterials on the intestinal barrier are also reported.

Indexed as

crossinghuman exposurein vitro intestinal barriernanoparticlesnew approach methodologiesuptake

Identifiers

PMID40801733
PMCPMC12348799

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.